BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 11, 2007
View Archived Issues
Novel series of anticancer compounds disclosed in recent patents
Read More
Recent Inotek patent reports new agents for treating urinary incontinence
Read More
Novel diagnostic agents imparted in recent patents
Read More
Cytyc completes acquisition of Adeza Biomedical
Read More
Genta files appeal against FDA decision on Genasense for CLL
Read More
Lilly completes acquisition of Hypnion
Read More
Survival benefit for lenalidomide plus low-dose dexamethasone in multiple myeloma
Read More
Immune Response changing name to Orchestra Therapeutics
Read More
MM-093 begins pilot study in autoimmune uveitis
Read More
Amgen updates Vectibix progress
Read More
IND clearance for phase II study of CollaRx Bupivacaine Implant in hysterectomy
Read More
Vekacia demonstrates efficacy in vernal keratoconjunctivitis phase III trial
Read More
Erbitux and platinum-based chemotherapy increases survival in SCCHN
Read More
PRT-054021 effective and safe for VTE prevention after knee replacement surgery
Read More
Tovaxin reduces annualized relapse rate in MS
Read More
Zentase meets endpoints in phase III exocrine pancreatic insufficiency trials
Read More
Positive findings for guanilib in animal models of experimental colitis
Read More
New Nav1.8 channel blockers with potential utility in chronic pain management
Read More
Ariad receives FDA feedback on pivotal study of AP-23573 for metastatic sarcoma
Read More
NP-1 begins two phase IIb trials for neuropathic pain
Read More
Phase II trial studies glufosfamide for soft tissue sarcoma
Read More
Alteon and Oxis expand licensing deal
Read More
Phase IIa Alzheimer's study of MEM-1003 completes enrollment
Read More
Phase II study of Curaxin CBLC-102 in prostate cancer advances to next stage
Read More
Novel PARP-1 inhibitor described by Abbott
Read More
NDA filing for local dental anesthetic reversal agent NV-101
Read More
HepaGam B approved to prevent hepatitis B recurrence in liver transplant patients
Read More
Intrinsa launched in U.K.
Read More